Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2026-03-25 4:03 pm | N/A N/A | Addex Therapeutics Ltd. | ADXN | Mills Roger CHIEF MEDICAL OFFICER | 0 | $0 | 835,976 (Direct) | View |
Ownership | 2026-03-25 4:03 pm | N/A N/A | Addex Therapeutics Ltd. | ADXN | Lawton Vincent Michael Director | 0 | $0 | 3,009,585 (Direct) | View |
Ownership | 2026-03-25 4:02 pm | 2018-01-01 2027-12-31 | Addex Therapeutics Ltd. | ADXN | Teyssedou Lenaic Nathanael PRINCIPAL ACCOUNTING OFFICER | 0 | $0 | 602,908 (Direct) | View |
Ownership | 2026-03-25 4:01 pm | N/A N/A | Addex Therapeutics Ltd. | ADXN | Kalinichev Mikhail HEAD OF TRANSLATIONAL SCIENCE | 0 | $0 | 506,765 (Direct) | View |
Ownership | 2026-03-25 4:01 pm | N/A N/A | Addex Therapeutics Ltd. | ADXN | Hill Raymond George Director | 0 | $0 | 1,638,639 (Direct) | View |
Ownership | 2026-03-18 11:07 am | N/A N/A | Addex Therapeutics Ltd. | ADXN | Dyer Timothy Mark Chief Executive Officer 10% Owner | 0 | $0 | 20,218,775 (Direct) | View |
Ownership | 2026-03-18 11:06 am | N/A N/A | Addex Therapeutics Ltd. | ADXN | Nunn Jason Raleigh Director | 0 | $0 | 269,561 (Direct) | View |
Ownership | 2026-03-18 11:06 am | N/A N/A | Addex Therapeutics Ltd. | ADXN | Manke Isaac Director | 0 | $0 | 269,561 (Direct) | View |